ViTrack is an entirely new approach to blood pressure (BP) measurement
Based on Dynocardia’s proprietary method, VITrack technology non-invasively monitors the intra-arterial pressure waveform in large arteries to directly and continuously measure systolic and diastolic BP
DISCOVERING A FUNDAMENTALLY NEW, NON-INVASIVE METHOD
Dynocardia has developed a proprietary method to directly measure systolic and diastolic BP based on spatiotemporal-force distribution on blood vessel walls and surrounding tissue
PROPRIETARY OPTOMECHANICAL SENSOR
Dynocardia’s optomechanical tactile sensor array can measure spatiotemporal-force distribution at the micron level.
Based on this proprietary method and technology, Dynocardia has developed ViTrack, the first standalone, wearable, cuff-less, continuous, non-invasive blood pressure monitoring (cNIBP) device
ViTrack provides calibrated continuous, intravascular pressure waveforms from which central blood pressure, arterial stiffness, respiratory patterns, heart rate, heart function, arrhythmias, peripheral resistance, cardiac output, cardiac filling pressures, and other hemodynamic parameters can be measured
TECHNOLOGY EVALUATED IN CLINICAL STUDIES
Per preliminary testing to industry standards, ViTrack methodology is shown to be as accurate as the gold-standard auscultatory method
ViTrack IS A PLATFORM TECHNOLOGY WITH BROAD APPLICATIONS IN THE HOSPITAL—AND BEYOND
There is significant need for accurate, continuous, and non-invasive BP measurement throughout the healthcare industry.
Continuity of care:
■ ICU
■ Critical care
■ Operating room
■ Dialysis
■ EMS
Outpatient:
■ Home monitoring
■ Wellness & prevention
■ Chronic disease management
■ Telemedicine